The Perfect Cup? Coffee-Derived Polyphenols and Their Roles in Mitigating Factors Affecting Type 2 Diabetes Pathogenesis

Type 2 diabetes (T2D) is a growing health concern with an estimated 462 million people having been diagnosed worldwide. T2D is characterized by chronically elevated blood glucose and insulin resistance, which culminate in a diminished function of the β-cell mass in its later stages. This can be perpetuated by and result in inflammation, excess reactive oxygen species production, obesity, and the dysregulation of multiple cellular pathways. Many naturally occurring small molecules have been investigated in terms of their roles in modulating glucose homeostasis and β-cell function. Many of these compounds can be found in commonly used sources of food and drink. Interestingly, a correlation has been observed between coffee consumption and T2D incidence. However, the specific compounds responsible for this correlation and their mechanisms are still somewhat undetermined. This paper reviews recent research findings on the effects of several polyphenols that are either found in coffee or are metabolites of compounds found in coffee (enterodiol, enterolactone, matairesinol, secoisolariciresinol, kaempferol, quercetin, and chlorogenic acid) on glucose homeostasis and health complications associated with glucose dysregulation, with a special emphasis on their potential anti-diabetic effects. The factors that affect polyphenol content in coffee are also addressed.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:29

Enthalten in:

Molecules (Basel, Switzerland) - 29(2024), 4 vom: 06. Feb.

Sprache:

Englisch

Beteiligte Personen:

Chapple, Brooke [VerfasserIn]
Woodfin, Seth [VerfasserIn]
Moore, William [VerfasserIn]

Links:

Volltext

Themen:

β-cell function
Chlorogenic acid
Coffee
Enterodiol
Enterolactone
Glucose
IY9XDZ35W2
Insulin resistance
Journal Article
Kaempferol
Matairesinol
Polyphenols
Quercetin
Review
Secoisolariciresinol

Anmerkungen:

Date Completed 26.02.2024

Date Revised 27.02.2024

published: Electronic

Citation Status MEDLINE

doi:

10.3390/molecules29040751

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM36888483X